{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:47:02Z","timestamp":1782928022032,"version":"3.54.5"},"reference-count":67,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2021,4,1]]},"DOI":"10.1001\/jamadermatol.2020.5598","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T15:00:44Z","timestamp":1615993244000},"page":"421","source":"Crossref","is-referenced-by-count":32,"title":["Mixed Individual-Aggregate Data on All-Cause Mortality in Bullous Pemphigoid"],"prefix":"10.1001","volume":"157","author":[{"given":"Billal","family":"Tedbirt","sequence":"first","affiliation":[{"name":"Department of Dermatology, Centre Hospitalier Universitaire Rouen, Rouen, France"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U1234, Centre de R\u00e9f\u00e9rence des Maladies Bulleuses Auto-immunes, Normandie University, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Gillibert","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Centre Hospitalier Universitaire Rouen, Normandie University, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Andrieu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Centre Hospitalier Universitaire Rouen, Rouen, France"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U1234, Centre de R\u00e9f\u00e9rence des Maladies Bulleuses Auto-immunes, Normandie University, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"H\u00e9bert","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Centre Hospitalier Universitaire Rouen, Rouen, France"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U1234, Centre de R\u00e9f\u00e9rence des Maladies Bulleuses Auto-immunes, Normandie University, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Bastos","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Centre Hospitalier Universitaire Rouen, Rouen, France"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U1234, Centre de R\u00e9f\u00e9rence des Maladies Bulleuses Auto-immunes, Normandie University, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil J.","family":"Korman","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark B. Y.","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, National Skin Centre, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Pekin Union Medical College Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Borradori","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Bern University Hospital, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Begonia","family":"Cort\u00e9s","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Geneva University Hospital, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Chan","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Gangnam Severance Hospital, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e0","family":"Gual","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital of China Medical University, Shenyang, China"},{"name":"Department of Dermatology, The First Hospital of China Medical University, Shenyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carilyn N.","family":"Wieland","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet A.","family":"Fairley","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Iowa, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Ezzedine","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Henri Mondor, University Hospital, Cr\u00e9teil, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Joly","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Centre Hospitalier Universitaire Rouen, Rouen, France"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U1234, Centre de R\u00e9f\u00e9rence des Maladies Bulleuses Auto-immunes, Normandie University, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"doi200078r1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/jid.2010.301","article-title":"Risk factors for bullous pemphigoid in the elderly: a prospective case-control study.","volume":"131","author":"Bastuji-Garin","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"12","key":"doi200078r3","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1046\/j.1365-4362.1999.00754.x","article-title":"Re-evaluation of the natural course of bullous pemphigoid: a prospective study.","volume":"38","author":"Kyriakis","year":"1999","journal-title":"Int J Dermatol"},{"issue":"4","key":"doi200078r4","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jaad.2008.07.022","article-title":"Mortality of bullous pemphigoid: an evaluation of 223 patients and comparison with the mortality in the general population in the United States.","volume":"59","author":"Parker","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"doi200078r5","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/j.0022-202X.2004.22504.x","article-title":"Mortality rate of bullous pemphigoid in a US medical center.","volume":"122","author":"Colbert","year":"2004","journal-title":"J Invest Dermatol"},{"key":"doi200078r6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4274\/Turkderm","article-title":"Bullous pemphigoid in Erzurum: a 10 year retrospective study.","volume":"49","author":"Kizilyel","year":"2015","journal-title":"Turkderm"},{"issue":"3","key":"doi200078r8","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/j.0022-202X.2005.23628.x","article-title":"Sepsis associated with dermatologic hospitalization is not the cause of high mortality of bullous pemphigoid in Europe.","volume":"124","author":"Garcia-Doval","year":"2005","journal-title":"J Invest Dermatol"},{"issue":"6","key":"doi200078r9","first-page":"758","article-title":"Risk of death in bullous pemphigoid: a retrospective database study in Finland.","volume":"96","author":"F\u00f6rsti","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"8","key":"doi200078r10","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/jid.2012.35","article-title":"Incidence and mortality of bullous pemphigoid in France.","volume":"132","author":"Joly","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"7","key":"doi200078r11","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1001\/archderm.138.7.903","article-title":"Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age.","volume":"138","author":"Rzany","year":"2002","journal-title":"Arch Dermatol"},{"issue":"4","key":"doi200078r12","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0190-9622(92)70085-T","article-title":"Lack of predictive factors for the clinical course of bullous pemphigoid.","volume":"26","author":"Venning","year":"1992","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"doi200078r13","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1001\/archderm.141.6.691","article-title":"Prediction of survival for patients with bullous pemphigoid: a prospective study.","volume":"141","author":"Joly","year":"2005","journal-title":"Arch Dermatol"},{"issue":"15","key":"doi200078r15","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting: Meta-analysis of Observational Studies in Epidemiology (MOOSE) group.","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"doi200078r16","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-analyses: the PRISMA statement.","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"12","key":"doi200078r17","doi-asserted-by":"publisher","first-page":"A61","DOI":"10.1016\/j.annder.2019.09.038","article-title":"Efficacy and tolerance of prednisone at 0.5mg\/kg\/day in initial treatment of bullous pemphigoid [in French].","volume":"146","author":"Bastos","year":"2019","journal-title":"Ann Dermatol V\u00e9n\u00e9r\u00e9ol"},{"issue":"5","key":"doi200078r18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.","volume":"346","author":"Joly","year":"2002","journal-title":"N Engl J Med"},{"issue":"4","key":"doi200078r19","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/jdv.12065","article-title":"Mortality of bullous pemphigoid in the first year after diagnosis: a retrospective study in a Spanish medical centre.","volume":"28","author":"Gual","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"doi200078r20","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/bjd.2011.165.issue-2","article-title":"Mortality of bullous pemphigoid in Switzerland: a prospective study.","volume":"165","author":"Cort\u00e9s","year":"2011","journal-title":"Br J Dermatol"},{"issue":"1","key":"doi200078r21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jaad.2014.02.030","article-title":"Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009.","volume":"71","author":"Brick","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi200078r22","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1001\/archdermatol.2012.2994","article-title":"Mortality of bullous pemphigoid in China.","volume":"149","author":"Li","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"1","key":"doi200078r23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1684\/ejd.2012.1906","article-title":"Treatment and mortality rate of bullous pemphigoid in China: a hospital-based study.","volume":"23","author":"Zhang","year":"2013","journal-title":"Eur J Dermatol"},{"issue":"4","key":"doi200078r24","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jaad.2014.05.006","article-title":"Mortality of patients with bullous pemphigoid in Korea.","volume":"71","author":"Lee","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"doi200078r25","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/bjd.2014.170.issue-6","article-title":"Mortality of bullous pemphigoid in Singapore: risk factors and causes of death in 359 patients seen at the National Skin Centre.","volume":"170","author":"Cai","year":"2014","journal-title":"Br J Dermatol"},{"issue":"12","key":"doi200078r26","doi-asserted-by":"publisher","first-page":"A96","DOI":"10.1016\/j.annder.2019.09.098","article-title":"Mortality in bullous pemphigoid: individual patient data meta-analysis on 12 international studies [in French].","volume":"146","author":"Tedbirt","year":"2019","journal-title":"Ann Dermatol V\u00e9n\u00e9r\u00e9ol"},{"issue":"12","key":"doi200078r27","first-page":"1223","article-title":"Immediate treatment of bullous pemphigus with a corticosteroid-cyclophosphamide combination [in French].","volume":"113","author":"Ta\u00efeb","year":"1986","journal-title":"Ann Dermatol Venereol"},{"key":"doi200078r28","article-title":"Bullous pemphigoid and its prognostic: retrospective study of 33 patients [in French].","volume":"16","author":"Devendeville","year":"1991","journal-title":"Rev G\u00e9riatr"},{"issue":"7","key":"doi200078r34","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1111\/jdv.v34.7","article-title":"Anti-BP180 autoantibody levels at diagnosis correlate with 1-year mortality rates in patients with bullous pemphigoid.","volume":"34","author":"Monshi","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"doi200078r35","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/bjd.2017.177.issue-5","article-title":"An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone.","volume":"177","author":"Sticherling","year":"2017","journal-title":"Br J Dermatol"},{"issue":"6","key":"doi200078r36","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1111\/bjd.15405","article-title":"Increased frequency of multiple sclerosis among patients with bullous pemphigoid: a population-based cohort study on comorbidities anchored around the diagnosis of bullous pemphigoid.","volume":"176","author":"Kibsgaard","year":"2017","journal-title":"Br J Dermatol"},{"issue":"18","key":"doi200078r37","first-page":"1229","volume":"62","author":"Bernard","year":"1986","journal-title":"Sem H\u00f4p Paris"},{"key":"doi200078r38","first-page":"331","article-title":"Corticosteroid treatment, risk factor of pemphigoid: retrospective analysis of 62 cases [in French].","volume":"18","author":"Michel","year":"1999","journal-title":"Nouv Dermatol"},{"issue":"4","key":"doi200078r39","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/archderm.134.4.465","article-title":"High risk of death in elderly patients with extensive bullous pemphigoid.","volume":"134","author":"Roujeau","year":"1998","journal-title":"Arch Dermatol"},{"issue":"3","key":"doi200078r40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.annder.2015.12.016","article-title":"Impact of neurological diseases on the prognosis of bullous pemphigoid: a retrospective study of 178 patients [in French].","volume":"143","author":"Chevalier","year":"2016","journal-title":"Ann Dermatol Venereol"},{"issue":"12","key":"doi200078r41","doi-asserted-by":"publisher","first-page":"S164","DOI":"10.1016\/j.annder.2018.09.219","article-title":"Prognostic factors of bullous pemphigoid in 329 patients [in French].","volume":"145","author":"Nespoulous","year":"2018","journal-title":"Ann Dermatol V\u00e9n\u00e9r\u00e9ol"},{"issue":"12","key":"doi200078r42","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.annder.2009.10.182","article-title":"Epidemiology of bullous pemphigoid in Guadeloupe (French West Indies) [in French].","volume":"136","author":"Cordel","year":"2009","journal-title":"Ann Dermatol Venereol"},{"issue":"12","key":"doi200078r43","doi-asserted-by":"publisher","first-page":"A161","DOI":"10.1016\/j.annder.2019.09.215","article-title":". One- and three-year mortality in patients with bullous pemphigoid treated as first-line with intensive local corticosteroid therapy [in French].","volume":"146","author":"Cantegrit","year":"2019","journal-title":"Ann Dermatol V\u00e9n\u00e9r\u00e9ol"},{"issue":"4","key":"doi200078r44","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/bjd.v183.4","article-title":"Feasibility and healthcare costs of superpotent topical corticosteroid therapy in bullous pemphigoid: a prospective, observational study in an academic centre in France.","volume":"183","author":"Clap\u00e9","year":"2020","journal-title":"Br J Dermatol"},{"issue":"10","key":"doi200078r45","doi-asserted-by":"publisher","first-page":"e432","DOI":"10.1111\/ijd.2014.53.issue-10","article-title":"Incidence and mortality of bullous pemphigoid in north-east Poland (Podlaskie Province), 1999-2012: a retrospective bicentric cohort study.","volume":"53","author":"Serwin","year":"2014","journal-title":"Int J Dermatol"},{"issue":"9","key":"doi200078r46","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00403-017-1772-x","article-title":"Mortality in bullous pemphigoid and prognostic factors in 1st and 3rd year of follow-up in specialized centre in Poland.","volume":"309","author":"Kalinska-Bienias","year":"2017","journal-title":"Arch Dermatol Res"},{"issue":"5, pt 1","key":"doi200078r47","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0190-9622(99)70156-8","article-title":"Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid.","volume":"40","author":"Heilborn","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"doi200078r48","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1001\/archderm.144.5.612","article-title":"A retrospective analysis of patients with bullous pemphigoid treated with methotrexate.","volume":"144","author":"Kjellman","year":"2008","journal-title":"Arch Dermatol"},{"issue":"12","key":"doi200078r49","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1016\/j.annder.2018.09.006","article-title":"Bullous pemphigoid treated with methotrexate: safety profile based on renal function at diagnosis [in French].","volume":"145","author":"Fisch","year":"2018","journal-title":"Ann Dermatol V\u00e9n\u00e9r\u00e9ol"},{"issue":"4","key":"doi200078r50","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000345625","article-title":"Mortality rate in bullous pemphigoid: a retrospective monocentric cohort study.","volume":"225","author":"Cort\u00e9s","year":"2012","journal-title":"Dermatology"},{"issue":"6146","key":"doi200078r51","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1136\/bmj.2.6146.1190","article-title":"Azathioprine plus prednisone in treatment of pemphigoid.","volume":"2","author":"Burton","year":"1978","journal-title":"BMJ"},{"issue":"2","key":"doi200078r52","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/bjd.2005.153.issue-2","article-title":"Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland.","volume":"153","author":"Gudi","year":"2005","journal-title":"Br J Dermatol"},{"key":"doi200078r53","article-title":"Incidence, prevalence and mortality of bullous pemphigoid in England 1998-2017: a population-based cohort study.","author":"Persson","year":"2020","journal-title":"Br J Dermatol"},{"issue":"2 suppl 1","key":"doi200078r54","first-page":"AB94","article-title":"Regional audit of bullous pemphigoid.","volume":"64","author":"Angit","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"doi200078r55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta21100","article-title":"A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200?mg\/day) with that of oral prednisolone (0.5?mg\/kg\/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) trial.","volume":"21","author":"Chalmers","year":"2017","journal-title":"Health Technol Assess"},{"key":"doi200078r56","first-page":"1491","article-title":"Epidemiological survey of the patients with bullous pemphigoid hospitalized in Alzahra Hospital, Isfahan, Iran, during the years 2006-2015.","volume":"36","author":"Mokhtari","year":"2019","journal-title":"J Isfahan Med School"},{"issue":"1","key":"doi200078r57","first-page":"72","article-title":"Mortality in patients with bullous pemphigoid: a retrospective cohort study, systematic review and meta-analysis.","volume":"99","author":"Kridin","year":"2019","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"doi200078r58","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00403-018-1875-z","article-title":"Mortality and risk factors among Israeli bullous pemphigoid patients.","volume":"311","author":"Rozenblat","year":"2019","journal-title":"Arch Dermatol Res"},{"key":"doi200078r59","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2336\/nishinihonhifu.66.183","article-title":"Statistical observation of bullous pemphigoid patients reported at the Dermatology Clinic, Ryukyus University Hospital [in Japanese].","volume":"66","author":"Kanamori","year":"2004","journal-title":"Nishi Nihon Hifuka"},{"issue":"2","key":"doi200078r60","first-page":"235","article-title":"A retrospective statistical analysis of prognostic factors for a lethal outcome in 52 elderly Japanese patients with bullous pemphigoid [in Japanese].","volume":"125","author":"Sasai","year":"2015","journal-title":"Jap J Dermatol"},{"issue":"1","key":"doi200078r61","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5021\/ad.2018.30.1.13","article-title":"Mortality and comorbidity profiles of patients with bullous pemphigoid in Korea.","volume":"30","author":"Jeon","year":"2018","journal-title":"Ann Dermatol"},{"issue":"3","key":"doi200078r62","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/ced.2006.31.issue-3","article-title":"Clinicoepidemiological features and course of 43 cases of bullous pemphigoid in Kuwait.","volume":"31","author":"Nanda","year":"2006","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"doi200078r63","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jaad.2015.01.029","article-title":"Infectious complications in bullous pemphigoid: an analysis of risk factors.","volume":"72","author":"Phoon","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi200078r65","first-page":"66","article-title":"Prevalence and clinical features of Thai patients with bullous pemphigoid.","volume":"29","author":"Kulthanan","year":"2011","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"1","key":"doi200078r66","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.piel.2019.03.002","article-title":"Autoimmune blistering diseases: clinical characterization, therapeutic response and mortality in a university center in Chile [in Spanish].","volume":"35","author":"Carvajal Aguilera","year":"2020","journal-title":"Piel"},{"issue":"9","key":"doi200078r67","first-page":"1137","article-title":"Bullous pemphigoid: the latest in diagnosis, prognosis, and therapy.","volume":"134","author":"Korman","year":"1998","journal-title":"Arch Dermatol"},{"key":"doi200078r7","author":"Chang"},{"key":"doi200078r32","volume-title":"Life Table Forecasting with the Gompertz Distribution","author":"Pflaumer","year":"2007"},{"key":"doi200078r2","unstructured":"De Rocco? F. Pemphigoide bulleuse: devenir, facteurs pronostiques, traitement: a propos de 130 observations. Master\u2019s thesis. Universit\u00e9 Lille-II; 1986."},{"key":"doi200078r14","unstructured":"National Institute for Health Research. Mortality in bullous pemphigoid: a systematic review and meta-analysis combining individual patient data and aggregate data. CRD42020164085. Accessed November 29, 2020. https:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?RecordID=164085"},{"key":"doi200078r29","unstructured":"Depaire? F. Traitement des pemphigoides bulleuses par t\u00e9tracyclines. Master\u2019s thesis. Universit\u00e9 Montpellier I; 1995."},{"key":"doi200078r30","unstructured":"Wells GA, Shea B, O'Connell D, et al; Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Published 1999. Accessed November 29, 2020. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"key":"doi200078r31","unstructured":"World Population Prospects, Population Division, United Nations. Standard projections (estimates and projection variants). Published August 2019. Accessed October 29, 2019. https:\/\/population.un.org\/wpp\/Download\/Standard\/Mortality\/"},{"key":"doi200078r33","unstructured":"Trikalinos? TA, Trow? P, Schmid? CH. Simulation-based comparison of methods for meta-analysis of proportions and rates. Agency for Healthcare Research and Quality; 2013. Accessed November 29, 2020. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK179162\/"},{"key":"doi200078r64","unstructured":"Wei? L. Clinical analysis of 163 cases of bullous pemphigoid. Master\u2019s thesis. China Medical University; 2018."}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2777609\/jamadermatology_tedbirt_2021_oi_200078_1618863523.77937.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T12:19:27Z","timestamp":1619093967000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2777609"}},"subtitle":["A Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2020.5598","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,1]]}}}